Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Drug shortages in the U.S. are limited primarily to generic injectables and a few key disease areas, according to an IMS Institute for Healthcare Informatics study released Monday.


Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now

Copyright © 2018 ALM Media Properties, LLC. All Rights Reserved.